Literature DB >> 26173498

Chemistry and biology of the compounds that modulate cell migration.

Etsu Tashiro1, Masaya Imoto2.   

Abstract

Cell migration is a fundamental step for embryonic development, wound repair, immune responses, and tumor cell invasion and metastasis. Extensive studies have attempted to reveal the molecular mechanisms behind cell migration; however, they remain largely unclear. Bioactive compounds that modulate cell migration show promise as not only extremely powerful tools for studying the mechanisms behind cell migration but also as drug seeds for chemotherapy against tumor metastasis. Therefore, we have screened cell migration inhibitors and analyzed their mechanisms for the inhibition of cell migration. In this mini-review, we introduce our chemical and biological studies of three cell migration inhibitors: moverastin, UTKO1, and BU-4664L.

Entities:  

Keywords:  14-3-3; 5-Lipoxygenase; Cell migration; Cysteinyl leukotriene receptor 1; Farnesyltransferase; Lamellipodia; Rac1

Mesh:

Substances:

Year:  2015        PMID: 26173498     DOI: 10.1007/s10295-015-1654-1

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  33 in total

Review 1.  Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

Authors:  K Kaibuchi; S Kuroda; M Amano
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Coactivation of Rac1 and Cdc42 at lamellipodia and membrane ruffles induced by epidermal growth factor.

Authors:  Kazuo Kurokawa; Reina E Itoh; Hisayoshi Yoshizaki; Yusuke Ohba Takeshi Nakamura; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

3.  Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor.

Authors:  E C Lerner; Y Qian; A D Hamilton; S M Sebti
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

Review 4.  The Rho GTPases in macrophage motility and chemotaxis.

Authors:  G E Jones; W E Allen; A J Ridley
Journal:  Cell Adhes Commun       Date:  1998

Review 5.  Cell migration in tumors.

Authors:  Hideki Yamaguchi; Jeffrey Wyckoff; John Condeelis
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

Review 6.  The great escape: when cancer cells hijack the genes for chemotaxis and motility.

Authors:  John Condeelis; Robert H Singer; Jeffrey E Segall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

7.  Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.

Authors:  Pierre-Olivier Angrand; Inmaculada Segura; Pamela Völkel; Sonja Ghidelli; Rebecca Terry; Miro Brajenovic; Kristina Vintersten; Rüdiger Klein; Giulio Superti-Furga; Gerard Drewes; Bernhard Kuster; Tewis Bouwmeester; Amparo Acker-Palmer
Journal:  Mol Cell Proteomics       Date:  2006-09-06       Impact factor: 5.911

8.  Chemistry and biology of moverastins, inhibitors of cancer cell migration, produced by Aspergillus.

Authors:  Yasushi Takemoto; Hidenori Watanabe; Kenji Uchida; Koji Matsumura; Koichi Nakae; Etsu Tashiro; Kazutoshi Shindo; Takeshi Kitahara; Masaya Imoto
Journal:  Chem Biol       Date:  2005-12

9.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.

Authors:  Mercedes Pozuelo Rubio; Kathryn M Geraghty; Barry H C Wong; Nicola T Wood; David G Campbell; Nick Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

10.  5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation.

Authors:  Shigeyuki Magi; Yasushi Takemoto; Hiroki Kobayashi; Masato Kasamatsu; Takahiro Akita; Ayako Tanaka; Kei Takano; Etsu Tashiro; Yasuhiro Igarashi; Masaya Imoto
Journal:  Cancer Sci       Date:  2014-01-28       Impact factor: 6.716

View more
  1 in total

Review 1.  New tricks for human farnesyltransferase inhibitor: cancer and beyond.

Authors:  Jingyuan Wang; Xue Yao; Jin Huang
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.